Lilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study PressReach · Mar 9, 2025
Q32 Bio Presents Results from SIGNAL-AA Part A Clinical Trial Evaluating Bempikibart in Patients with Alopecia Areata at the 2025 American Academy of Dermatology Meeting PressReach · Mar 9, 2025
Luraco Technologies Announces Fraternal Order of Police (FOP) Care Chair Contest to Support First Responders' Wellness PressReach · Mar 8, 2025
Community Health Development Partners and Barrick-Operated Nevada Gold Mines Announce the Opening of Full-Service Infusion Center in Elko, Nevada PressReach · Mar 8, 2025
Protecting Our Most Vulnerable: The urgent need to make critical prenatal substance exposure services accessible for children statewide PressReach · Mar 8, 2025
MWC 2025 | Huawei Showcases Scenario-based Solutions at MWC For Intelligent Healthcare PressReach · Mar 7, 2025
GBM Health Holding Announces $1.5M Innovate BC Grant to Advance Breakthroughs in Precision Medicine and Sustainable Biotech PressReach · Mar 7, 2025
Richards Packaging Income Fund announces 2024 Results and Mr. John Glynn as Director, Trustee and Chief Executive Officer PressReach · Mar 7, 2025
Beneq and Exosens Collaborate on Lead-Free MCPs with ALD, Enhancing Precision, Performance, and Manufacturing Efficiency PressReach · Mar 6, 2025
